OCC
Diabetes Magna Plus™

A New Surgical Option for Type 2 Diabetes

Diabetes Magna Plus combines sleeve gastrectomy with magnetic metabolic technology designed to improve metabolic health and blood sugar control in appropriately selected patients.

See If You Are a Candidate Schedule a Consultation

Individual results vary. No outcome can be guaranteed. Treatment recommendations require evaluation by a qualified physician.

The Challenge

Why Type 2 Diabetes Remains So Difficult to Control

Many people living with Type 2 Diabetes continue to struggle despite medications, insulin therapy, dietary changes, exercise programs, and even newer medications such as GLP-1 therapies.

Rising A1C levels

Increasing medication requirements

Progressive weight gain

Insulin dependence

Ongoing metabolic disease progression

Limited durability of lifestyle changes alone

Diabetes Magna Plus was developed to address both obesity and metabolic disease simultaneously through a metabolic surgery approach.

Overview

What Is Diabetes Magna Plus?

Diabetes Magna Plus combines sleeve gastrectomy, magnetic duodeno-ileal diversion technology, and metabolic surgical principles. The goal is to create metabolic changes that may help improve glucose regulation, insulin sensitivity, and long-term metabolic health in appropriately selected patients.

  • Sleeve Gastrectomy
  • Magnetic Duodeno-Ileal Diversion Technology
  • Metabolic Surgical Principles
  • Results vary among individuals.
Simplified Metabolic Pathway
Stomach
Duodenum
Ileum

The combined sleeve and magnetic duodeno-ileal connection is designed to engage hormonal and nutrient-sensing pathways involved in glucose regulation.

Mechanism

How Does Diabetes Magna Plus Work?

The procedure is designed to influence multiple metabolic pathways associated with Type 2 Diabetes.

Hormonal signaling

Insulin sensitivity

Glucose regulation

Appetite regulation

Weight reduction

Nutrient-sensing pathways

The procedure utilizes magnetic compression technology based on the MagDI™ platform. Explore the Science & Evidence Center →

Comparison

How Diabetes Magna Plus Differs From Other Treatments

Each treatment plays a different role. Suitability depends on individual evaluation by a qualified physician.

ConsiderationLifestyleGLP-1 MedsSleeve GastrectomyDiabetes Magna Plus
Weight LossVariableOften meaningfulSubstantialSubstantial
Blood Sugar ImprovementPossibleOftenOftenDesigned to support
Daily Medication DependenceMaintainedOngoing injectionsMay decreaseMay decrease
Procedure RequiredNoNoYesYes
Long-Term ManagementContinuous effortContinuous therapyLifelong follow-upLifelong follow-up

This table is educational and does not imply superiority of any treatment. Results vary among individuals.

Evidence

Built on Emerging Scientific Evidence

Magnetic metabolic technology has received FDA regulatory authorization and has been evaluated through published clinical studies and ongoing research programs.

FDA Regulatory Status
Learn more
Published Clinical Studies
Learn more
Safety Data
Learn more
Ongoing Research
Learn more
Explore the Science & Evidence Center
Eligibility

Who May Be a Candidate?

Potential candidates may include adults with Type 2 Diabetes and related metabolic disease. Final determination requires evaluation by a qualified physician.

  • Adults with Type 2 Diabetes
  • Individuals with obesity
  • Patients requiring multiple diabetes medications
  • Patients using insulin
  • Patients seeking alternatives to long-term medication escalation
  • Patients experiencing metabolic disease progression
Read full candidate selection criteria →
Safety

Understanding Risks and Limitations

Like all medical and surgical treatments, Diabetes Magna Plus carries potential risks and limitations.

Bleeding
Infection
Obstruction
Nutritional deficiencies
Reoperation
Failure to achieve desired outcomes

Long-term outcomes continue to be evaluated through ongoing clinical follow-up. Review the full Safety & Risks page →

Editorial Oversight

Medical Review & Clinical Oversight

The educational content on this website is reviewed for medical accuracy, clarity, and patient safety by experienced bariatric and metabolic surgery professionals. The purpose of this review is to help ensure that information about obesity treatment, bariatric surgery, metabolic health, revisional surgery, endoscopic procedures, GLP-1 medications, and long-term follow-up is presented responsibly and without exaggerated claims.

Medical Reviewers

Dr. Ariel Ortiz Lagardere, MD, FACS, FASMBS
Bariatric & Metabolic Surgeon — Founder and Director, Obesity Control Center

Dr. Ariel Ortiz Lagardere is a bariatric and metabolic surgeon with extensive experience in minimally invasive weight-loss surgery, metabolic disease treatment, international patient care, and surgical education. Public professional profiles describe him as board-certified in Mexico, a Fellow of the American College of Surgeons, a Fellow of the American Society for Metabolic and Bariatric Surgery, and an SRC-recognized Master Surgeon in Metabolic and Bariatric Surgery.

Dr. Arturo Martinez Gamboa, MD
Bariatric & Metabolic Surgeon — Obesity Control Center

Dr. Arturo Martinez Gamboa has been affiliated with Obesity Control Center since 2001. His publicly available professional biography describes advanced laparoscopic and bariatric training at Hospital Ramón y Cajal in Madrid, Spain. Surgical Review Corporation sources identify him as an SRC-accredited Master Surgeon in Metabolic & Bariatric Surgery and Bariatric Revisional Surgery.

Dr. Helmuth Billy, MD
Bariatric & Revisional Surgery Specialist — Ventura, California

Dr. Helmuth Billy is a bariatric surgeon specializing in laparoscopic bariatric surgery, revisional bariatric surgery, and multidisciplinary weight-loss care. Public ASMBS meeting biographies describe him as being in private practice since 1997, actively practicing bariatric surgery since 2000, serving as medical director at two MBSAQIP hospitals, and having a clinical interest in weight regain and revisional surgery.

Editorial Review Process

All medical content is periodically reviewed for accuracy, relevance, readability, and consistency with current medical knowledge and accepted bariatric and metabolic surgery principles. Content is intended to support informed decision-making and does not replace consultation with a qualified healthcare professional.

Educational Disclaimer

This website provides general educational information only. It does not provide medical advice, diagnosis, treatment recommendations, or guarantees of outcome. Candidacy for any medical, surgical, endoscopic, or medication-based treatment must be determined by a qualified healthcare professional after an individual evaluation.

Last reviewed: June 2026

References

Selected authoritative sources informing our educational content. External links open in a new tab; we do not control or endorse third-party content.

FAQ

Frequently Asked Questions

No medical or surgical treatment is described as a cure for Type 2 Diabetes. Metabolic surgery, including Diabetes Magna Plus, is designed to support improvements in glucose regulation and overall metabolic health in appropriately selected patients. Long-term outcomes vary among individuals and continue to be evaluated through ongoing clinical follow-up.
Patient Experiences

Patient Stories

Patient experiences will be shared here as they become available, with explicit consent and editorial review.

Individual patient experience. Results are not typical. Outcomes vary among individuals. No result can be guaranteed.

Find Out If Diabetes Magna Plus May Be Right For You

Schedule a consultation with our team to discuss your medical history, treatment goals, and candidacy.

See If You Are a Candidate Schedule Consultation

Educational information only. Not medical advice. Individual results vary. Treatment recommendations require evaluation by a qualified physician.

Book Consultation